Resources

This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

This document provides answers to frequently asked questions about the Meningitis Vaccine Project, including facts about meningococcal meningitis, the MenAfriVac™ vaccine, and next steps for the project.

From tracking tuberculosis in Africa to providing better maternal and child health care in India, PATH's work in health information systems is bridging the gap between global health and information and communication technology using a different approach—a user-driven enterprise architecture and technology that addresses user requirements. Find out more about PATH's work in digital health solutions.

Facilitated by project Optimize and conducted by a multidisciplinary group of partners, these landscape analyses highlight ongoing work related to five priority areas that comprise the vision for immunization supply systems in 2020. The analyses also highlight critical gaps that need to be addressed to achieve the vision. The five priority areas are vaccine and related products, supply system design, environmental impact, information systems, and human resources. The document is available as one large file or as six smaller files for easier downloading.

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade and was followed in 2013 by From Pipeline to Product: Malaria R&D Funding Needs Into the Next Decade.